Precision X-Ray Teams Up with Gilardoni for Blood Irradiation
Precision X-Ray Forms Strategic Partnership with Gilardoni
Precision X-Ray, Inc. has recently forged an exclusive distribution partnership with Gilardoni SpA, aimed at introducing the RADGIL2 blood irradiator to the US market. This innovative device is designed for the safe and effective X-ray irradiation of blood and its components. By utilizing the RADGIL2, healthcare facilities can significantly decrease the risks associated with transfusion-related diseases, particularly Transfusion-associated Graft versus Host Disease (TA-GvHD). This development offers a state-of-the-art alternative to traditional models that use Cesium-137, which poses various safety concerns.
Advantages of the RADGIL2 Blood Irradiator
Innovative Features for Patient Safety
The RADGIL2 stands out in the market due to its advanced features that enhance safety and efficiency. One notable aspect is its high dose rate, which accelerates the irradiation process, leading to faster treatment times. Additionally, the device incorporates rotating canister technology that ensures a consistent and uniform delivery of doses, improving the overall effectiveness of blood irradiation procedures.
CEO Insights on the Collaboration
Viktoriya Baytser, CEO of Precision X-Ray, expressed excitement about this partnership, stating, "Precision is proud and thrilled to partner with Gilardoni to deliver the RADGIL2 blood irradiator in the US. This collaboration will expand our influence in the medical field, reinforcing our commitment to innovative and reliable solutions in X-ray technology, particularly in critical areas like blood irradiation."
Statements from Gilardoni's Leadership
Marco Gilardoni, CEO of Gilardoni SpA, shared his enthusiasm for the alliance, affirming, "We are delighted to partner with a company that is highly regarded in the X-ray irradiation market. Precision's values align with ours in striving to enhance the standard of care for blood irradiation. We are eager to collaborate in establishing the RADGIL2 as the benchmark for blood irradiation in the US."
Explore Precision’s Offering
For further details about the RADGIL2 or other innovative products and services provided by Precision X-Ray, interested parties can visit Precision's official website.
About Precision X-Ray, Inc.
Precision X-Ray is recognized as the largest global manufacturer of cabinet X-ray irradiation systems. With a focus on delivering safe, reliable, and reproducible results, the company has been at the forefront of technological advancement since the early 2000s, catering to partners across various sectors including commercial, agricultural, and academic fields.
About Gilardoni SpA
Established in 1947, Gilardoni SpA has become a leading player in the fields of X-ray and ultrasonic equipment for non-destructive testing and medical applications. With a dedicated workforce of over 200 employees worldwide, the company has been a key innovator in industrial radioscopy since 1968.
Frequently Asked Questions
What is the RADGIL2 blood irradiator?
The RADGIL2 is an advanced X-ray device designed for safe and effective irradiation of blood and blood components, reducing risks related to transfusion-related diseases.
Who are the partners involved in this initiative?
Precision X-Ray, Inc. and Gilardoni SpA have partnered to introduce this cutting-edge technology to the US market.
What are the benefits of using RADGIL2 over traditional methods?
RADGIL2 provides a safer, more efficient method of blood irradiation, with faster processing times and enhanced dose delivery uniformity.
How does this partnership impact the medical field?
This partnership aims to improve patient safety and care standards in blood irradiation, reflecting a commitment to innovative healthcare solutions.
Where can I learn more about Precision X-Ray's products?
For further inquiries about the RADGIL2 or additional products, you can visit Precision X-Ray’s official website for comprehensive information.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Exploring Dividend Income for Retirement: Strategies and Stocks
- Westgate Resorts Offers Complimentary Getaway for Veterans
- Advancing Blood Clot Treatments: Inari Medical's DEFIANCE Trial
- Thor Equities Expands Global Logistics Efforts with New Sale
- Revolutionizing Liver Toxicity Testing with 3D Microtissues
- E Source Celebrates Utility Leaders at Forum 2024 Awards
- CIRO Schedules Hearing for Alleged Misconduct by Advisor
- BioNJ and Medidata Join Forces for Clinical Equity in Trials
- Dominion Energy's Strategic Plan for Sustainable Power Growth
- Exelixis Achieves Court Victory in Patent Dispute with MSN
Recent Articles
- eIVF Unveils Advanced Embryology Dashboard to Enhance Care
- Elematec and MEDIROM Forge Strategic Partnership for Innovation
- Ingram Micro Aims for Significant Valuation with IPO Plans
- Accenture and Google Team Up for AI Solutions in Government
- SSE Opts for Independence Over EDP Merger Talks
- Unlocking Speed in Data Analysis with AnswerRocket's Max AI
- How CardioOne and DeepScribe are Revolutionizing Cardiology AI
- LOBO EV Technologies Celebrates Record Growth in Shipments
- Engagement with Indigenous Communities on Carbon Credits Sale
- Meritage Homes Welcomes Erin Lantz to Board of Directors
- JAGGAER Shines with EcoVadis Gold Medal for Sustainability
- Firefly Neuroscience Innovates Treatments for Women’s Mental Health
- Domino's Pizza Faces Lawsuit Over Securities Fraud Allegations
- Empowering Women Through Financial Independence: SoFi's Initiative
- Top Tech Stocks to Watch for Earnings Surprises This Season
- Bitcoin ETFs Experience Record Inflows Amid Growing Interest
- Dialpad Achieves $300M ARR Milestone, Strengthening AI Leadership
- Verizon's Survey Reveals Growth in AI Adoption Among SMBs
- kama.ai Welcomes New Leadership for Strategic Growth
- Worthington Steel Unveils Its First Sustainability Report for 2024
- Charles Schwab Achieves Record Assets & Revenue in Q3 2024
- Stride Inc. Excels as Finalist in Multiple Tech Education Awards
- Tetra Tech Secures $37.5 Million Contract for Urban Projects
- Red Cat's Exciting $1 Million Drone Contract with the Army
- Colbeck Capital Embraces Opportunities at Dallas Summit
- Abits Group Announces Details for Upcoming Shareholder Meeting
- Key Insights on ACM Research's P/E Ratio and Market Trends
- Journey Strategic Wealth Expands with New Advisor Partnerships
- Understanding the Rise of RTX Stock Amid Defense Contracts
- Navigating Gift Taxes for Family Home Down Payments
- White River Bancshares Achieves Record Third Quarter Profits
- OCI Global Declares Impressive USD 3.4 Billion Cash Distribution
- Transforming Sustainable Fashion with AI: Sellpy and Algolia Unite
- CNBC Highlights Top Stock Picks: Nvidia, PayPal and More
- Charles Schwab Corp Reports High Earnings, Shares Surge
- Babel Street’s SOC 2 Type 2 Assessment Enhances Security Standards
- Arteris Enhances AI Semiconductor Design with NoC Tiling
- Port Secures $35M Funding to Innovate Developer Portals
- Horace Mann to Reveal Financial Performance for Q3 2024
- Market Analysts Optimistic on Advance Auto Parts and More Stocks
- Revolutionizing Cancer Care: Myriad’s New Partnership with Flatiron
- PensionPro and Dynamis Join Forces to Enhance TPA Efficiency
- Maximizing Monthly Income With Morgan Stanley Stock Strategies
- Cybersecurity Threats Loom Over the 2024 U.S. Election
- Gloat Unveils Cutting-Edge AI Tools for Workforce Flexibility
- Cooper Investors Warns Frontier Communications Board on Acquisition
- Amplitude Expands Its Digital Solutions with Command AI
- Q.E.P. CO., Inc. Shows Strong Performance for Fiscal 2025
- NNN REIT Declares Common Dividend, Reflects Strong Performance
- CT REIT Announces Upcoming Distribution for Trust Units